Home » Newsletters » BioWorld Science

BioWorld Science

June 20, 2001

View Archived Issues

Chronic therapy with ximelagatran for preventing stroke in patients with atrial fibrillation

Clinical hold placed on GM-611 pending analysis of animal toxicity studies

Licensing agreement signed for Chugai psoriasis therapeutic

Adipocyte-specific protein and essential hypertension

Phase I trials commence with Ilex Oncology's ILX-651 and NM-3

Progen receives U.S. approval to begin phase II trial of PI-88

MTX-HSA is superior to free MTX in a mouse model of rheumatoid arthritis

Risedronate approved in additional E.U. countries for reducing hip fractures

Synthetic halichondrin B analogues show high antitumor potency and wide therapeutic window

FDA issues nonapprovable letter for Zelnorm as IBS treatment

BLS successfully develops GMP manufacturing process for troponin I

Nonpeptide FSH mimetics useful for the treatment of infertility

New GLA-60 analogues designed at Sankyo inhibit macrophage activity

Roche and Trimeris expand partnership agreement for HIV fusion inhibitors

Inhibitors of tyrosine kinase from Merck useful as antiangiogenic agents

Reminyl shows potential for treatment of cerebrovascular disease-related dementia

Positive modulators of nicotinic receptor agonists in the AstraZeneca pipeline

Cannabinoid CB1 antagonists and their use reported by French lab

Plant extracts with significant efficacy in animal model of NIDDM

CollaGenex seeks pan-European approval for Periostat tablets

European launch of Zometa for TIH under way

Phase I/II study of ISIS-14803 shows dose-dependent viral load reductions

Role of calcineurin in cardiac hypertrophy and subsequent heart failure

Repligen extends phase II autism trial; biological markers/response to secretin relation reported

Two drugs will be reviewed by Endocrinologic and Metabolic Drugs Advisory Committee next month

Medarex and Genmab to codevelop antibody therapeutics for inflammation

Sanofi-Synthelabo designs selective CB2 antagonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...